Full name: N-acetyl galactosaminidase, alpha

Gene type: protein coding

RefSeq status: VALIDATED

Summary: Predicted to enable alpha-N-acetylgalactosaminidase activity; alpha-galactosidase activity; and protein homodimerization activity. Predicted to be involved in several processes, including glycoside catabolic process; glycosylceramide catabolic process; and oligosaccharide metabolic process. Predicted to be located in lysosome. Predicted to be active in cytoplasm. Is expressed in nervous system and skeleton. Human ortholog(s) of this gene implicated in Kanzaki disease; Schindler disease type 1; angiokeratoma; and neuroaxonal dystrophy. Orthologous to human NAGA (alpha-N-acetylgalactosaminidase). [provided by Alliance of Genome Resources, Apr 2022]

Expression: Ubiquitous expression in colon adult (RPKM 76.1), kidney adult (RPKM 46.4) and 28 other tissues

Gene size: 9344bp

Exon count: 10